US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist
  • 1.840
  • +0.040+2.22%
Trading Jul 5 09:57 ET
48.38MMarket Cap-1735P/E (TTM)

LAVA Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LAVA Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

6.99M

+471.24%
EPS(YoY)

-0.02

+96.23%
Analyst Rating

Strong Buy

Jun 28, 2024

LAVA Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q16.440M / 3.238M--
--2023/Q4325.040K / 5.796M--
--2023/Q348.790K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q16.440M / 3.238M--
--2023/Q4325.040K / 5.796M--
--2023/Q348.790K / 0.000--

Unlock Free Earnings Estimates

LAVA Therapeutics Earnings Reports

  • LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 21 16:10 ET

  • LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 21 07:06 ET

  • LAVA Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Mar 20 16:09 ET

  • LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 16, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 28, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg